WebAug 9, 2024 · Raghuram Selvaraju-- H.C. Wainwright -- Analyst. Thanks very much for taking my questions. Again, not to beat a dead horse, I wanted to ask whether you had any feedback from the FDA as to whether ... WebJul 14, 2024 · In a July 8 research note, analyst Robert Burns reported that H.C. Wainwright & Co. had upgraded its rating on Aerpio Pharmaceuticals Inc. (ARPO:NASDAQ) to Buy from Neutral following the announcement of the biopharma's merger with Aadi Bioscience.
Breaking News: AVXL latest news. - The Fly
WebDr. Raghuram Selvaraju is a Chairman at RELIEF THERAPEUTICS Holding AG, a Managing Director & Senior Healthcare Analyst at H. C. Wainwright & Co. LLC and a Managing … Web1 day ago · HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Raises Price Target to $18 - Arcadia Biosciences (NASDAQ:RKDA) - Benzinga 413.45 –% –% 7.28% 2.0105% 340.34 0.01% 189.69 0.02% TLT... growth consultancy
Expert - Ram Selvaraju
WebAnalyst. H.C. Wainwright. Dr. Raghuram Selvaraju. Protalix BioTherapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Protalix BioTherapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Protalix BioTherapeutics or ... WebHC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Annovis Bio (NYSE:ANVS) with a Buy rating and announces Price Target of $40. 14 8 8 comments Best Add a Comment M_Zlu • 2 mo. ago HC Wainwright is a reputable sell-side investment bank. WebOct 2, 2024 · Raghuram Selvaraju, Ph.D., MBA, is Managing Director of Equity Research and Senior Healthcare Analyst at H.C. Wainwright & Co, LLC, Research Division. Dr. Selvaraju … filtering text roblox